The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Segidrin     hydrazine; sulfuric acid

Synonyms: Sehydrin, PubChem15719, CCRIS 336, H4766_ALDRICH, LS-318, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Segidrin


High impact information on Segidrin


Chemical compound and disease context of Segidrin


Biological context of Segidrin


Anatomical context of Segidrin


Associations of Segidrin with other chemical compounds


Gene context of Segidrin


Analytical, diagnostic and therapeutic context of Segidrin


  1. Effect of hydrazine sulphate on whole-body protein breakdown measured by 14C-lysine metabolism in lung cancer patients. Tayek, J.A., Heber, D., Chlebowski, R.T. Lancet (1987) [Pubmed]
  2. Influence of hydrazine sulfate on abnormal carbohydrate metabolism in cancer patients with weight loss. Chlebowski, R.T., Heber, D., Richardson, B., Block, J.B. Cancer Res. (1984) [Pubmed]
  3. Randomized placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancer. Loprinzi, C.L., Kuross, S.A., O'Fallon, J.R., Gesme, D.H., Gerstner, J.B., Rospond, R.M., Cobau, C.D., Goldberg, R.M. J. Clin. Oncol. (1994) [Pubmed]
  4. Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a randomized placebo-controlled, double-blind phase III study of the Cancer and Leukemia Group B. Kosty, M.P., Fleishman, S.B., Herndon, J.E., Coughlin, K., Kornblith, A.B., Scalzo, A., Morris, J.C., Mortimer, J., Green, M.R. J. Clin. Oncol. (1994) [Pubmed]
  5. Alternative cancer cures: "unproven" or "disproven"? Vickers, A. CA: a cancer journal for clinicians. (2004) [Pubmed]
  6. Hydrazine sulfate protects D-galactosamine-sensitized mice against endotoxin and tumor necrosis factor/cachectin lethality: evidence of a role for the pituitary. Silverstein, R., Turley, B.R., Christoffersen, C.A., Johnson, D.C., Morrison, D.C. J. Exp. Med. (1991) [Pubmed]
  7. Indirect alkylation of CBA mouse liver DNA and RNA by hydrazine in vivo. A possible mechanism of action as a carcinogen. Quintero-Ruiz, A., Paz-Neri, L.L., Villa-Treviño, S. J. Natl. Cancer Inst. (1981) [Pubmed]
  8. Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer. Loprinzi, C.L., Goldberg, R.M., Su, J.Q., Mailliard, J.A., Kuross, S.A., Maksymiuk, A.W., Kugler, J.W., Jett, J.R., Ghosh, C., Pfeifle, D.M. J. Clin. Oncol. (1994) [Pubmed]
  9. A review of the drug treatment of cachexia associated with cancer. Gagnon, B., Bruera, E. Drugs (1998) [Pubmed]
  10. Enhancement by hydrazine sulfate of antitumor effectiveness of cytoxan, mitomycin C, methotrexate and bleomycin, in walker 256 carcinosarcoma in rats. Gold, J. Oncology (1975) [Pubmed]
  11. Clinical approaches to nutritional support in cancer. Tchekmedyian, N.S. Current opinion in oncology. (1993) [Pubmed]
  12. Potentiation by clofibrate of in-vivo tumor inhibition by hydrazine sulfate and cytotoxic agents, in Walker 256 carcinosarcoma. Gold, J. Cancer Biochem. Biophys. (1978) [Pubmed]
  13. Hydrazine sulfate influence on nutritional status and survival in non-small-cell lung cancer. Chlebowski, R.T., Bulcavage, L., Grosvenor, M., Oktay, E., Block, J.B., Chlebowski, J.S., Ali, I., Elashoff, R. J. Clin. Oncol. (1990) [Pubmed]
  14. Virulence of Wolinella recta in a murine abscess model. Kesavalu, L., Holt, S.C., Crawley, R.R., Borinski, R., Ebersole, J.L. Infect. Immun. (1991) [Pubmed]
  15. On the relationship between the activity of acetylation, growth of experimental tumors and efficacy of their suppression by hydrazine sulphate. Dilman, V.M., Anisimov, V.N., Kolosov, A.I., Bulovskaya, L.N. Oncology (1976) [Pubmed]
  16. Testing the mutagenic potency of chemical substances in a linear host-mediated assay. I. Experimental microbiological basis. Grafe, A., Lorenz, R., Vollmar, J. Mutat. Res. (1975) [Pubmed]
  17. Mutagenic and recombinogenic activity of hydrazine sulphate in Saccharomyces cerevisiae. Vasudeva, M., Vashishat, R.K. Mutat. Res. (1985) [Pubmed]
  18. S(-3) state of the water oxidase in photosystem II. Messinger, J., Seaton, G., Wydrzynski, T., Wacker, U., Renger, G. Biochemistry (1997) [Pubmed]
  19. How useful are unconventional cancer treatments? Ernst, E., Cassileth, B.R. Eur. J. Cancer (1999) [Pubmed]
  20. The effect of hydrazine sulfate on prostate cancer growth. Kamradt, J.M., Pienta, K.J. Oncol. Rep. (1998) [Pubmed]
  21. Hydrazine sulfate selectively modulates the TNF response to endotoxin in mouse macrophages. Jia, F., Morrison, D.C., Silverstein, R. Circ. Shock (1994) [Pubmed]
  22. Changes in methyl-sensitive restriction sites of liver DNA from hamsters chronically exposed to hydrazine sulfate. Zheng, H., Shank, R.C. Carcinogenesis (1996) [Pubmed]
  23. Enzymatic sulfation of galactose residue of keratan sulfate by chondroitin 6-sulfotransferase. Habuchi, O., Hirahara, Y., Uchimura, K., Fukuta, M. Glycobiology (1996) [Pubmed]
  24. Perinatal carcinogenicity of isoniazid (INH) in Swiss mice. Menon, M.M., Bhide, S.V. J. Cancer Res. Clin. Oncol. (1983) [Pubmed]
  25. Point mutations at the thymidine kinase locus in L5178Y mouse lymphoma cells. II. Test validation and interpretation. Amacher, D.E., Paillet, S.C., Turner, G.N., Ray, V.A., Salsburg, D.S. Mutat. Res. (1980) [Pubmed]
  26. The role of glycolysis and gluconeogenesis in the cytoprotection of neuroblastoma cells against 1-methyl 4-phenylpyridinium ion toxicity. Mazzio, E., Soliman, K.F. Neurotoxicology (2003) [Pubmed]
  27. Anorexia in end-stage renal disease: pathophysiology and treatment. Aguilera, A., Selgas, R., Diéz, J.J., Bajo, M.A., Codoceo, R., Alvarez, V. Expert opinion on pharmacotherapy. (2001) [Pubmed]
  28. Lung tumour incidence in mice treated with hydrazine sulphate. Bhide, S.V., D'Souza, R.A., Sawai, M.M., Ranadive, K.J. Int. J. Cancer (1976) [Pubmed]
  29. Pyridoxine therapy in a patient with severe hydrazine sulfate toxicity. Nagappan, R., Riddell, T. Crit. Care Med. (2000) [Pubmed]
  30. Protein and amino acid metabolism in cancer cachexia: investigative techniques and therapeutic interventions. Pisters, P.W., Pearlstone, D.B. Critical reviews in clinical laboratory sciences. (1993) [Pubmed]
  31. Fatal hepatorenal failure associated with hydrazine sulfate. Hainer, M.I., Tsai, N., Komura, S.T., Chiu, C.L. Ann. Intern. Med. (2000) [Pubmed]
  32. Effect of carcinogenic components of cigarette smoke on in vivo production of murine interferon. Sonnenfeld, G., Hudgens, R.W. Cancer Res. (1983) [Pubmed]
  33. Hydrazine sulfate and preneoplastic exfoliated cells. Norman, R.L. Oncology (1975) [Pubmed]
  34. The potential use of hydrazine as an alternative to peroxidase in a biosensor: comparison between hydrazine and HRP-based glucose sensors. Rahman, M.A., Won, M.S., Shim, Y.B. Biosensors & bioelectronics. (2005) [Pubmed]
WikiGenes - Universities